HCA Healthcare, Inc. (NYSE:HCA) is Prescott Group Capital Management L.L.C.’s 7th Largest Position

Prescott Group Capital Management L.L.C. lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 27,108 shares of the company’s stock after selling 6,500 shares during the quarter. HCA Healthcare comprises approximately 1.8% of Prescott Group Capital Management L.L.C.’s portfolio, making the stock its 7th biggest position. Prescott Group Capital Management L.L.C.’s holdings in HCA Healthcare were worth $8,227,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. BDO Wealth Advisors LLC increased its holdings in HCA Healthcare by 60.0% in the 2nd quarter. BDO Wealth Advisors LLC now owns 160 shares of the company’s stock worth $49,000 after buying an additional 60 shares in the last quarter. Covestor Ltd increased its holdings in HCA Healthcare by 122.7% in the 1st quarter. Covestor Ltd now owns 167 shares of the company’s stock worth $42,000 after buying an additional 92 shares in the last quarter. WASHINGTON TRUST Co increased its holdings in HCA Healthcare by 100.0% in the 2nd quarter. WASHINGTON TRUST Co now owns 180 shares of the company’s stock worth $55,000 after buying an additional 90 shares in the last quarter. Scissortail Wealth Management LLC bought a new stake in HCA Healthcare in the 1st quarter worth about $315,475,000. Finally, Capital Advisors Ltd. LLC grew its stake in shares of HCA Healthcare by 895.0% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 199 shares of the company’s stock valued at $60,000 after purchasing an additional 179 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 1.0 %

HCA Healthcare stock traded up $2.36 during mid-day trading on Monday, hitting $248.74. The company’s stock had a trading volume of 520,401 shares, compared to its average volume of 1,310,078. The company has a 50 day moving average of $242.32 and a 200-day moving average of $266.42. The stock has a market cap of $66.58 billion, a PE ratio of 12.12, a P/E/G ratio of 1.38 and a beta of 1.66. The company has a debt-to-equity ratio of 103.06, a quick ratio of 0.99 and a current ratio of 1.15. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $304.86.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $3.91 EPS for the quarter, missing the consensus estimate of $3.97 by ($0.06). HCA Healthcare had a net margin of 9.05% and a return on equity of 2,040.32%. The business had revenue of $16.21 billion during the quarter, compared to the consensus estimate of $15.77 billion. On average, research analysts anticipate that HCA Healthcare, Inc. will post 18.18 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 28th. Stockholders of record on Thursday, December 14th will be given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.96%. The ex-dividend date of this dividend is Wednesday, December 13th. HCA Healthcare’s payout ratio is 11.81%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on HCA. Stephens restated an “overweight” rating and set a $280.00 price target on shares of HCA Healthcare in a research note on Friday, November 10th. Cantor Fitzgerald reiterated an “overweight” rating and set a $315.00 price objective on shares of HCA Healthcare in a research note on Thursday, September 14th. Citigroup cut their price objective on HCA Healthcare from $324.00 to $279.00 and set a “buy” rating for the company in a research note on Wednesday, October 25th. Mizuho lowered their price target on HCA Healthcare from $325.00 to $275.00 and set a “buy” rating on the stock in a report on Wednesday, October 25th. Finally, Oppenheimer boosted their price target on HCA Healthcare from $310.00 to $315.00 and gave the stock an “outperform” rating in a report on Friday, July 28th. Two research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $296.59.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.